TREACE MEDICAL CONCEPTS INC (TMCI)

US89455T1097 - Common Stock

10.4  +0.1 (+0.97%)

After market: 10.4 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
94.4M
64.46%		141.8M
50.21%		187.118M
31.96%		227.27M
21.46%
EBITDA
YoY % growth
-15.81M
-849.29%		-32.67M
-106.64%		-46.076M
-41.03%		-29.384M
36.23%
EBIT
YoY % growth
-16.5M
-1,933.33%		-34.8M
-110.91%		-51.428M
-47.78%		-58.378M
-13.51%
Operating Margin
-17.48%-24.54%-27.48%-25.69%
EPS
YoY % growth
-0.41-0.77
-87.80%		-0.81
-5.19%		-0.95
-16.75%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.31
-34.31%
Revenue
Q2Q % growth		50.046M
18.59%
EBITDA
Q2Q % growth		-10.484M
EBIT
Q2Q % growth		-19.358M
-40.48%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.10
-25.00%		-0.09-0.01-10.69%
Q3 2023
Q2Q % growth		 -0.28
-27.27%		-0.27-0.01-5.00%
Q2 2023
Q2Q % growth		 -0.20
35.48%		-0.240.0417.73%
Q1 2023
Q2Q % growth		 -0.23
-43.75%		-0.230.001.24%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 62.212M
25.00%		61.761M451K0.73%
Q3 2023
Q2Q % growth		 40.76M
23.29%		42.896M-2.136M-4.98%
Q2 2023
Q2Q % growth		 41.95M
39.97%		41.665M285K0.68%
Q1 2023
Q2Q % growth		 42.2M
45.27%		40.03M2.17M5.42%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -63.08% 0% -45.84%
Revenue0% 0.01% 0% 0.61%